Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MDRX - Veradigm Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm


MDRX - Veradigm Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - March 1, 2023) - Block & Leviton is investigating Veradigm, Inc. (NASDAQ: MDRX) for potential securities law violations. Investors who have lost money in their Veradigm investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/mdrx.

What is this all about?

After the market closed on February 28, 2023, Veradigm, Inc. disclosed "that in conjunction with its year-end audit procedures it has detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters, resulting in a mis-statement to reported revenues during those periods."

Veradigm's disclosure indicated the control failures are related to a software tool the Company implemented in Q3 2021 to assist with FASB compliance.

Shares of Veradigm dropped more than 12% in trading on March 1, 2023.

Who is eligible?

Anyone who purchased Veradigm stock and has lost money may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.

What is Block & Leviton doing?

Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

What should you do next?

If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at cases@blockleviton.com, or by phone at (617) 398-5600.

Why should you contact Block & Leviton?

Many law firms have issued releases about this matter; most of those firms do not actually litigate securities class actions. Block & Leviton is a law firm that actually litigates cases. We are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, or call (617) 398-5600 or email cases@blockleviton.com with any questions.

This notice may constitute attorney advertising.

CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (617) 398-5600
Email: cases@blockleviton.com

SOURCE: Block & Leviton LLP
www.blockleviton.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/156851

Stock Information

Company Name: Allscripts Healthcare Solutions Inc.
Stock Symbol: MDRX
Market: NASDAQ
Website: allscripts.com

Menu

MDRX MDRX Quote MDRX Short MDRX News MDRX Articles MDRX Message Board
Get MDRX Alerts

News, Short Squeeze, Breakout and More Instantly...